This update serves to clarify that Affymetrix does not make cDNA arrays, as we erroneously reported on Monday. Incyte manufactures such arrays. Affy makes synthesized arrays for oligonucleotides that allow scientists to manufacture their own cDNA arrays.

NEW YORK, Oct. 15 – A US District Court has dismissed two claims filed by Affymetrix which asserted that Incyte had violated its “two-color” patent while also denying Incyte’s motion to find another Affymetrix patent invalid, the companies said on Monday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.